濟(jì)南奧德凱藥業(yè)有限公司生產(chǎn)供應(yīng)利拉利汀CAS NO.:668270-12-0

中文名稱利拉利汀中文同義詞LINAGLIPTIN利拉利汀(BI-1356);利格利汀;歐唐寧;利拉利汀1KG;利拉利汀API;利納利汀;利拉利汀原料藥;利格列汀英文名稱Linagliptin英文同義詞linagliptin;8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione;(R)-8-(3-Amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione;1H-Purine-2,6-dione,8-((3R)-3-amino-1-piperidinyl)-7-(2-butynyl)-3,7-dihydro-3-methyl-1-((4-methyl-2-quinazolinyl)methyl)-;Bi1356;Ondero;8-[(3R)-3-AMino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-Methyl-1-[(4-Methyl-2-quinazolinyl)Methyl]-1H-purine-2,6-dione;8-[(3R)-3-AMino-1-piperidinyl]-7-(2-butynyl)-3,7-dihydro-3-Methyl-1-[(4-Methyl-2-quinazolinyl)Methyl]-1H-purine-2,6-dCAS號668270-12-0分子式C25H28N8O2分子量472.54EINECS號1308068-626-2相關(guān)類別醫(yī)藥中間體，醫(yī)藥原料，精細(xì)化工品。;對照品-雜質(zhì)對照品;對照品;糖尿病;中間體;其他雜環(huán);原料藥;醫(yī)藥中間體;醫(yī)藥原料;利拉利汀;小分子抑制劑;醫(yī)藥原料藥;Amines;Aromatics;Heterocycles;Intermediates&FineChemicals;Pharmaceuticals;API;Pharmaceuticalrawmaterial;Inhibitor;Linagliptin;TRADJENTA;蛋白酶;醫(yī)藥抑制劑;醫(yī)用原料;對照品-中藥對照品;藥物雜質(zhì)及中間體;化工原料藥;標(biāo)準(zhǔn)品;中藥對照品;原料藥及中間體;化學(xué)試劑;化學(xué)產(chǎn)品Mol文件668270-12-0.mol